Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05446259 · ClinicalTrials.gov registry record
Degenerative Cervical Myelopathy Repository
A clinical trial of Cervical Myelopathy, sponsored by Francis Farhadi.
- Recruiting
- Registry status
- 245
- Enrollment target
- 1
- Study location
NCT05446259: Recruiting study of Cervical Myelopathy, sponsored by Francis Farhadi.
NCT05446259 is a study of Cervical Myelopathy that is actively recruiting participants, run by Francis Farhadi. The registered enrollment target is 245 participants, above the 58-participant average among 4 other Cervical Myelopathy trials with a reported enrollment target (322% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05446259, a study of Cervical Myelopathy, is actively recruiting participants, sponsored by Francis Farhadi.
- RECRUITING
- Registry status
- 245 participants
- Enrollment target
- 1
- Study location
Study Summary
To create a research repository of patients with known degenerative cervical myelopathy (DCM) and a control cohort of subjects who have non-myelopathic spinal disease. This repository will be used to assess functional and/or biological measures that may allow for improved prediction of symptomatic progression and response to treatment in patients with DCM. In addition, this repository will be used to develop a risk assessment scale to accurately predict functional outcomes following operative management of DCM.
Primary Outcome
This study is to determine biomarkers associated with DCM and analyze objective clinical measures to determine more predictable and potentially effective treatments for patients diagnosed with cervical myelopathy.
Conditions Studied
Interventions
- OTHER Standard clinical care procedures and outcome measurements.
Study Locations (1)
Kentucky
- University of Kentucky - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 245 participants |
| Start Date | 2022-07-13 |
| Est. Completion | 2028-05 |
What NCT05446259 shows while recruiting
NCT05446259 is an observational study that tracks outcomes without assigning an intervention. The registered 245 participants enrollment target is mid-sized for trials with a published cap, above the 58-participant average among 4 other Cervical Myelopathy trials with a reported enrollment target (322% higher).
The record links to 1 condition, with Cervical Myelopathy appearing as the primary indexed condition, and to 1 intervention - of which Standard clinical care procedures and outcome measurements. is the first listed.
NCT05446259 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT05446259 about?
NCT05446259 is a clinical study titled "Degenerative Cervical Myelopathy Repository". To create a research repository of patients with known degenerative cervical myelopathy (DCM) and a control cohort of subjects who have non-myelopathic spinal disease. This repository will be used to assess functional and/or biological measures that may allow for improved prediction of symptomatic p...
What is the current status of trial NCT05446259?
This trial is currently recruiting. The enrollment target is 245 participants. The study started on 2022-07-13. Estimated completion is 2028-05.
What conditions does trial NCT05446259 study?
This clinical trial studies the following conditions: Cervical Myelopathy.
What interventions are being tested in trial NCT05446259?
The interventions under investigation include: Standard clinical care procedures and outcome measurements. (OTHER).
Who is sponsoring clinical trial NCT05446259?
This trial is sponsored by Francis Farhadi, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05446259 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Myelopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating Safety and Feasibility of Transcutaneous Spinal Cord Stimulation Following Traumatic and Non-Traumatic Spinal Cord Injury: A Pilot Study
RECRUITING · NA
-
Cervical Myelopathy in Hip Fracture Patients
RECRUITING · NA
-
Spinal Cord Associative Plasticity Study
RECRUITING · Early Phase 1
-
Targeting Cervical Epidural Spinal Cord Stimulation for Functional Recovery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03645928 · 245 participants · Phase 2
Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors
- NCT04718168 · 245 participants · NA
GORE® ENFORM Biomaterial Product Study
- NCT05145127 · 245 participants · Phase 3
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
- NCT06057051 · 245 participants · NA
Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle Glaucoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI